Abstract
Hereby, we report the case of a 12-year-old girl developing oligoarthritis and progressing into a polyarticular form. Rheumatoid factor was positive, and juvenile idiopathic arthritis (JIA) was diagnosed. After a poor response to DMARDs, an anti-TNF agent (infliximab) was initiated, but to be discontinued due to an allergic reaction. The same complication was observed with the fully human derivative, adalimumab. At the age of 22, the patient presented septicemia with severe anemia and subsequent development of leukopenia, myocarditis with heart failure, and ANA, aSm, aSS-A, aCL positives, and nephrotic syndrome. These new clinical manifestations fulfilled the classification criteria for the diagnosis of systemic lupus erythematosus. Due to the poor therapeutic responses for both diseases, alternative medical options have to be considered, such as targeted therapy with anti-CD20 or interleukin-6 receptor antagonist monoclonal antibodies. This patient may also be a candidate for autologous hemopoietic stem cell transplantation.
Abbreviations
- JIA:
-
Juvenile idiopathic arthritis
- RA:
-
Rheumatoid arthritis
- EULAR:
-
European league against rheumatism
- ILAR:
-
International league against rheumatism
- RF:
-
Rheumatoid factor
- SLE:
-
Systemic lupus erythematosus
- ANA:
-
Antinuclear antibody
- a-dsDNA:
-
Antibody against double stranded
- a-CL:
-
Anti-cardiolipin antibodies
- aCCP:
-
Anti-citrullinated peptide antibody
- NSAID:
-
Non-steroidal anti-inflammatory drugs
- DMARDs:
-
Disease-modifying anti-rheumatic drugs
- ACPA:
-
Anti-citrullinated peptide antibody
- aSM:
-
Smith antigen
- aSS-A:
-
Sjögren syndrome A antigen
- ISN/RPS:
-
International society of nephrologist/renal pathology society
- ENA:
-
Anti-extractable-nuclear—antibody
- TNF-α:
-
Tumor-necrosis factor alfa
- E. coli:
-
Escherichia coli
- anti-TNF:
-
Anti-tumor-necrosis factor
- ATIL:
-
Anti-TNF-induced lupus
References
Özen S, Sothwood TR (2007) Juvenile idiopathic arthritis, Eular on-line course on rheumatic diseases-module n14
Russo RA, Katsicas MM (2009) Clinical remission in patients with systemic juvenile idiopathic arthritis treated with anti-tumor necrosis factor agents. J Rheumatol 5:1078–1082
Brewer EJ Jr, Bass J, Baum J et al (1977) Current proposed revision of JRA criteria. JRA criteria subcommittee of the diagnostic and therapeutic criteria committee of the American rheumatism section of the arthritis foundation. Arthritis Rheum 2:195–199
European League Against Rheumatism: EULAR Bulletin No. 4: Nomenclature and classification of arthritis in children. Basel, National Zeitung AG, 1977
Peety RE, Southwood TR, Manners P et al (2004) International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision. Edmonton 2001. J Rheumatology 31:390–392
Cassidy JT, Petty RE (2005) Oligoarthritis. In: Cassidy JT, Petty RE, Laxer R, Lidnsley C (eds) Textbook of pediatric rheumatology, 5th edn. Elsevier Saumders, Philadelphia, pp 274–290
Cassidy JT, Petty RE (2005) Polyarthritis. In: Cassidy JT, Petty RE, Laxer R, Lidnsley C (eds) Textbook of pediatric rheumatology, 5th edn. Elsevier Saumders, Philadelphia, pp 261–274
Agrawal V, Misra R, Aggrawal A (2002) Immune complexes contain immunglobulin a rheumatoid factor in serum and synovial fluid of patients with polyarticular juvenile rheumatoid arthritis. Rheumatology (Oxf) 41:466–467
Uziel Y, Pomeranz A, Brik R et al (1996) Seasonal onset of systemic-onset juvenile rheumatoid arthritis. J Pediatr 129:513–519
Bowyer S, Roettcher P (1996) Pediatric rheumatology clinic populations in the United States: results of a 3 year survey pediatric rheumatology database research group. J Rheumatol 23(11):1968–1974
Pain CE, McCann LJ (2009) Challenges in the management of juvenile idiopathic arthritis with etanercept. Biologics 3:127–139
Katsicas MM, Russo RA (2009) Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and/or infliximab. J Rheumatol 35(6):1151–1156
Ruperto N, Bazso A, Ravelli A et al (2007) Paediatric rheumatology international trials organization (PRINTO). Lupus 16(8):670–676 Review
Kanakoudi-Tsakalidou F, Tzimouli V et al (2008) The significance of persistent newly developed autoantibodies in JIA patients under long-term anti-TNF treatment. Cytokine 42(3):293–297
Hochberg MC (1997) Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725
Woo P, Laxer RM, Sherry DD (2007): Overlap syndromes. In Woo P, Laxer RM, Sherry DD (eds) Pediatric rheumatology in clinical practice, VIII. Springer, London, pp 90–97
Gregersen PK, Behrens TW (2006) Genetics of autoimmune diseases-disorders of autoimmune homeostasis. Nat Rev Genet 7:917–928
Icen M, Nicola PJ, Maradit-Kremers H et al (2009) Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortality. J Rheum 36(1):4–6
Amezcua-Guerra LM (2009) Overlap between systemic lupus erythematosus and rheumatoid arthritis: is it real or just an illusion? J Rheumatol 36(1):4–6
Ostendorf B, Scherer A, Specker C et al (2003) Jaccoud’s arthropathy in systemic lupus erythematosus: differentiation of deforming and erosive patterns by magnetic resonance imaging. Arthritis Rheum 48(1):157–165
Szer IS, Kimura Y, Malleson PN et al (2006) Arthritis in children and adolescents; juvenile idiopathic arthritis. Oxford University Press, UK
Cassidy JT, Petty RE (2005) Systemic lupus erythematosus. In: Cassidy JT, Petty RE, Laxer R, Lidnsley C (eds) Textbook of pediatric rheumatology, 5th edn. Elsevier Saumders, Philadelphia, p 342
DiKensoy O, Bayram N, Bingol A et al (2002) Bronchiolitis obliterans in a case of juvenile rheumatoid arthritis presented with pneumomediastinum. Respiration 69:100–102
Ozer S, Alehan D, Ozme S et al (1994) Mitral and aortic insufficiency in polyarticular juvenile rheumatoid arthritis. Pediat Cardiol 15:151–153
Uziel Y, Hen B, Cordoba M et al (1998) Lymphocytic interstitial pneumonitis preceding polyarticular juvenile rheumatoid arthritis. Clin Exp Rheumatol 16:617–619
Nossent J, Kiss E, Rozman B, Pokorny G et al. (2010) Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosus. Lupus. 2010. Apr 7. Epub ahead of print
Rohayem J, Leupold W, Paul K-D et al (2002) Pulmonary fibrosis and other clinical manifestation of small vessel vasculitis in a family with seropositive juvenile rheumatoid arthritis. Pediatr Pulmonol 33:65–70
Aringer M, Smolen JS (2008) The role of tumor necrosis factor-alpha in systemic lupus erythematosus. Arthritis Res Ther 10(1):202
Aringer M, Steiner G, Graninger WB et al (2007) Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosus. Arthritis Rheum 56(1):274–279
Williams EL, Gadola S, Edwards CJ (2009) Anti-TNF-induced lupus. Rheumatology 48(7):716–720
Lovell DJ, Reiff A, Jones OY et al (2003) Pediatric rheumatology collaborative study group. Long-term efficacy and safety of etanercept in children with polyarticular course juvenile rheumatoid arthritis. Arthritis Rheum 48:18–26
Debandt M, Vittecoq O, Descamps V et al (2003) Anti-TNF-alpha-induced systemic lupus syndrome. Clin Rheumatol 22(1):56–61
Lovell DJ, Reiff A, Jones OY et al (2006) Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum, pp 1987–1994
Unsal E, Arli AO, Akman H (2006) Lupus arthropathy: a case series of patients with rhupus. Clin Rheumatol 25(2):164–167
Fernández A, Quintana G, Rondón F et al (2006) Lupus arthropathy: a case series of patients with rhupus. Clin Rheumatol 25(2):164–167
Ragsdale CG, Petty RE, Cassidy JT et al (1980) The clinical progression of apparent juvenile rheumatoid arthritis to systemic lupus erythematosus. J Rheumatol 7(1):50–55
Acknowledgments
The authors are greatly thankful to Marco Gattorno MD, PhD (2nd Division of Pediatrics, EULAR Centre of Excellence in Rheumatology, Genova, Italy), Péter Fülöp, MD, PhD (1st Dept. of Internal Medicine, University of Debrecen Medical and Health Science Center, Debrecen, Hungary), Péter Szodoray MD, PhD (Institute of Immunology, Rikshospitalet, University of Oslo) for their kind remarks and recommendations.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bazsó, A., Sevcic, K., Orbán, I. et al. Overlapping juvenile idiopathic arthritis and systemic lupus erythematosus: a case report. Rheumatol Int 31, 695–698 (2011). https://doi.org/10.1007/s00296-010-1594-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-010-1594-z